Age-related genomic characterization and therapeutic targets in Chinese breast cancer: insights from prospective targeted sequencing and clinical data analysis.

With a median follow-up of 20.27 months (ranging from 0 to 285.2 months), young patients showed a trend toward reduced disease-free survival (DFS) in our center (Fig. 1 D, P = 0.148).

also in 53,322 other papers